UniProt ID | AL7A1_HUMAN | |
---|---|---|
UniProt AC | P49419 | |
Protein Name | Alpha-aminoadipic semialdehyde dehydrogenase | |
Gene Name | ALDH7A1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 539 | |
Subcellular Localization |
Cytoplasm, cytosol . Nucleus . Isoform 1: Mitochondrion . |
|
Protein Description | Multifunctional enzyme mediating important protective effects. Metabolizes betaine aldehyde to betaine, an important cellular osmolyte and methyl donor. Protects cells from oxidative stress by metabolizing a number of lipid peroxidation-derived aldehydes. Involved in lysine catabolism.. | |
Protein Sequence | MWRLPRALCVHAAKTSKLSGPWSRPAAFMSTLLINQPQYAWLKELGLREENEGVYNGSWGGRGEVITTYCPANNEPIARVRQASVADYEETVKKAREAWKIWADIPAPKRGEIVRQIGDALREKIQVLGSLVSLEMGKILVEGVGEVQEYVDICDYAVGLSRMIGGPILPSERSGHALIEQWNPVGLVGIITAFNFPVAVYGWNNAIAMICGNVCLWKGAPTTSLISVAVTKIIAKVLEDNKLPGAICSLTCGGADIGTAMAKDERVNLLSFTGSTQVGKQVGLMVQERFGRSLLELGGNNAIIAFEDADLSLVVPSALFAAVGTAGQRCTTARRLFIHESIHDEVVNRLKKAYAQIRVGNPWDPNVLYGPLHTKQAVSMFLGAVEEAKKEGGTVVYGGKVMDRPGNYVEPTIVTGLGHDASIAHTETFAPILYVFKFKNEEEVFAWNNEVKQGLSSSIFTKDLGRIFRWLGPKGSDCGIVNVNIPTSGAEIGGAFGGEKHTGGGRESGSDAWKQYMRRSTCTINYSKDLPLAQGIKFQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 2) | Acetylation | - | 15.54 | 19413330 | |
23 (in isoform 4) | Phosphorylation | - | 31.36 | - | |
30 | Phosphorylation | SRPAAFMSTLLINQP CCCHHHHHHHHHCCH | 14.95 | 25599653 | |
30 | Acetylation | SRPAAFMSTLLINQP CCCHHHHHHHHHCCH | 14.95 | 19413330 | |
39 | Phosphorylation | LLINQPQYAWLKELG HHHCCHHHHHHHHHC | 13.36 | 110745675 | |
57 | Acetylation | ENEGVYNGSWGGRGE CCCCCCCCCCCCCCE | 13.69 | 19413330 | |
67 | Phosphorylation | GGRGEVITTYCPANN CCCCEEEEEEECCCC | 19.52 | 28152594 | |
68 | Phosphorylation | GRGEVITTYCPANNE CCCEEEEEEECCCCC | 16.41 | 28152594 | |
69 | Phosphorylation | RGEVITTYCPANNEP CCEEEEEEECCCCCC | 6.44 | 24927040 | |
81 | Ubiquitination | NEPIARVRQASVADY CCCCHHHHHHHHHCH | 22.31 | 21890473 | |
84 | Phosphorylation | IARVRQASVADYEET CHHHHHHHHHCHHHH | 14.97 | 25159151 | |
88 | Phosphorylation | RQASVADYEETVKKA HHHHHHCHHHHHHHH | 13.11 | 110745683 | |
93 | 2-Hydroxyisobutyrylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | - | |
93 | Acetylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | 23236377 | |
93 | Succinylation | ADYEETVKKAREAWK HCHHHHHHHHHHHHH | 48.40 | 27452117 | |
94 | Acetylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | 30585379 | |
94 | Succinylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | - | |
94 | Succinylation | DYEETVKKAREAWKI CHHHHHHHHHHHHHH | 48.63 | - | |
100 | Acetylation | KKAREAWKIWADIPA HHHHHHHHHHCCCCC | 35.10 | 26051181 | |
109 | Ubiquitination | WADIPAPKRGEIVRQ HCCCCCCCCCHHHHH | 75.13 | 21890473 | |
124 | 2-Hydroxyisobutyrylation | IGDALREKIQVLGSL HHHHHHHHHHHHHHH | 31.82 | - | |
130 | Phosphorylation | EKIQVLGSLVSLEMG HHHHHHHHHHHHHHC | 22.80 | 20068231 | |
133 | Phosphorylation | QVLGSLVSLEMGKIL HHHHHHHHHHHCCEE | 24.73 | 20068231 | |
136 | Ubiquitination | GSLVSLEMGKILVEG HHHHHHHHCCEEEEC | 8.87 | 21890473 | |
136 | Sulfoxidation | GSLVSLEMGKILVEG HHHHHHHHCCEEEEC | 8.87 | 30846556 | |
163 | Sulfoxidation | YAVGLSRMIGGPILP HHHHHHHHHCCCCCC | 2.76 | 30846556 | |
171 | Phosphorylation | IGGPILPSERSGHAL HCCCCCCCCCCCCHH | 42.04 | 21406692 | |
222 | Phosphorylation | CLWKGAPTTSLISVA EECCCCCCHHHHHHH | 28.60 | 21406692 | |
223 | Phosphorylation | LWKGAPTTSLISVAV ECCCCCCHHHHHHHH | 22.07 | 21406692 | |
224 | Phosphorylation | WKGAPTTSLISVAVT CCCCCCHHHHHHHHH | 26.61 | 21406692 | |
227 | Phosphorylation | APTTSLISVAVTKII CCCHHHHHHHHHHHH | 14.87 | 21406692 | |
231 | Phosphorylation | SLISVAVTKIIAKVL HHHHHHHHHHHHHHH | 13.54 | 21406692 | |
249 | Phosphorylation | KLPGAICSLTCGGAD CCCCCEEECEECCCC | 22.17 | 21406692 | |
251 | Phosphorylation | PGAICSLTCGGADIG CCCEEECEECCCCHH | 7.88 | 21406692 | |
259 | Phosphorylation | CGGADIGTAMAKDER ECCCCHHHHHHCCCC | 17.37 | 21406692 | |
260 | Ubiquitination | GGADIGTAMAKDERV CCCCHHHHHHCCCCE | 7.24 | 21890473 | |
271 | Phosphorylation | DERVNLLSFTGSTQV CCCEEEEEEECCCHH | 24.75 | 21712546 | |
273 | Phosphorylation | RVNLLSFTGSTQVGK CEEEEEEECCCHHHH | 27.18 | 21712546 | |
275 | Phosphorylation | NLLSFTGSTQVGKQV EEEEEECCCHHHHHH | 16.77 | 21712546 | |
285 | Sulfoxidation | VGKQVGLMVQERFGR HHHHHHHHHHHHHHC | 2.11 | 30846556 | |
317 | Ubiquitination | DLSLVVPSALFAAVG CHHHHCHHHHHHHHC | 26.45 | 21890473 | |
324 | Ubiquitination | SALFAAVGTAGQRCT HHHHHHHCCCHHHCH | 12.72 | 29967540 | |
336 | Ubiquitination | RCTTARRLFIHESIH HCHHHHHHHHCHHHH | 3.84 | 21890473 | |
345 | Ubiquitination | IHESIHDEVVNRLKK HCHHHHHHHHHHHHH | 33.91 | 21890473 | |
352 | Malonylation | EVVNRLKKAYAQIRV HHHHHHHHHHHCCCC | 51.74 | 26320211 | |
352 | Ubiquitination | EVVNRLKKAYAQIRV HHHHHHHHHHHCCCC | 51.74 | 29967540 | |
354 | Phosphorylation | VNRLKKAYAQIRVGN HHHHHHHHHCCCCCC | 14.12 | 29496907 | |
361 | Ubiquitination | YAQIRVGNPWDPNVL HHCCCCCCCCCCCCC | 31.47 | 32015554 | |
362 | Ubiquitination | AQIRVGNPWDPNVLY HCCCCCCCCCCCCCC | 30.80 | 29967540 | |
375 | Ubiquitination | LYGPLHTKQAVSMFL CCCCCCHHHHHHHHH | 26.05 | 29967540 | |
379 | Phosphorylation | LHTKQAVSMFLGAVE CCHHHHHHHHHHHHH | 13.56 | 21406692 | |
388 | Ubiquitination | FLGAVEEAKKEGGTV HHHHHHHHHHCCCEE | 18.08 | 21890473 | |
389 | Ubiquitination | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 32015554 | |
389 | 2-Hydroxyisobutyrylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | - | |
389 | Acetylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 6570007 | |
389 | Succinylation | LGAVEEAKKEGGTVV HHHHHHHHHCCCEEE | 55.42 | 23954790 | |
390 | Ubiquitination | GAVEEAKKEGGTVVY HHHHHHHHCCCEEEE | 69.51 | 29967540 | |
390 | 2-Hydroxyisobutyrylation | GAVEEAKKEGGTVVY HHHHHHHHCCCEEEE | 69.51 | - | |
393 | Ubiquitination | EEAKKEGGTVVYGGK HHHHHCCCEEEECCE | 19.21 | 21890473 | |
402 | Ubiquitination | VVYGGKVMDRPGNYV EEECCEECCCCCCCC | 4.05 | 21890473 | |
411 | Ubiquitination | RPGNYVEPTIVTGLG CCCCCCCCEEEECCC | 19.85 | 29967540 | |
415 | Ubiquitination | YVEPTIVTGLGHDAS CCCCEEEECCCCCCH | 23.88 | 21890473 | |
424 | Ubiquitination | LGHDASIAHTETFAP CCCCCHHHCCCCCCC | 10.89 | 21890473 | |
436 | Ubiquitination | FAPILYVFKFKNEEE CCCEEEEEEECCHHH | 4.93 | 29967540 | |
439 | Acetylation | ILYVFKFKNEEEVFA EEEEEEECCHHHEEE | 65.13 | 20167786 | |
439 | Ubiquitination | ILYVFKFKNEEEVFA EEEEEEECCHHHEEE | 65.13 | 29967540 | |
452 | Ubiquitination | FAWNNEVKQGLSSSI EEEEHHHHHCCCCCC | 32.25 | 22817900 | |
457 | Phosphorylation | EVKQGLSSSIFTKDL HHHHCCCCCCCHHHH | 32.28 | 23403867 | |
458 | Phosphorylation | VKQGLSSSIFTKDLG HHHCCCCCCCHHHHH | 20.53 | 23403867 | |
462 | Acetylation | LSSSIFTKDLGRIFR CCCCCCHHHHHHHHH | 39.96 | - | |
464 | Ubiquitination | SSIFTKDLGRIFRWL CCCCHHHHHHHHHHH | 5.46 | 21890473 | |
472 | Ubiquitination | GRIFRWLGPKGSDCG HHHHHHHCCCCCCCE | 18.21 | 29967540 | |
473 | Ubiquitination | RIFRWLGPKGSDCGI HHHHHHCCCCCCCEE | 35.35 | 21890473 | |
478 | Glutathionylation | LGPKGSDCGIVNVNI HCCCCCCCEEEEEEC | 4.25 | 22555962 | |
491 | Ubiquitination | NIPTSGAEIGGAFGG ECCCCCCCCCCCCCC | 45.77 | 21890473 | |
500 | Acetylation | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 26051181 | |
500 | Ubiquitination | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 21890473 | |
500 | Ubiquitination | GGAFGGEKHTGGGRE CCCCCCCCCCCCCCC | 50.14 | 21890473 | |
509 | Ubiquitination | TGGGRESGSDAWKQY CCCCCCCCHHHHHHH | 25.45 | 21890473 | |
516 | Phosphorylation | GSDAWKQYMRRSTCT CHHHHHHHHHHCCCE | 6.72 | 28634298 | |
520 | Phosphorylation | WKQYMRRSTCTINYS HHHHHHHCCCEEEEC | 19.92 | 28634298 | |
521 | Phosphorylation | KQYMRRSTCTINYSK HHHHHHCCCEEEECC | 16.32 | 28634298 | |
523 | Phosphorylation | YMRRSTCTINYSKDL HHHHCCCEEEECCCC | 16.61 | 25944883 | |
526 | Phosphorylation | RSTCTINYSKDLPLA HCCCEEEECCCCCCC | 17.16 | 28152594 | |
527 | Phosphorylation | STCTINYSKDLPLAQ CCCEEEECCCCCCCC | 18.40 | 28152594 | |
528 | Ubiquitination | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 21890473 | |
528 | Acetylation | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 23954790 | |
528 | Malonylation | TCTINYSKDLPLAQG CCEEEECCCCCCCCC | 53.58 | 26320211 | |
537 | Ubiquitination | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | 21890473 | |
537 | Succinylation | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | - | |
537 | Succinylation | LPLAQGIKFQ----- CCCCCCCCCC----- | 44.53 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AL7A1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL7A1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL7A1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
EPS8_HUMAN | EPS8 | physical | 21988832 | |
ASNS_HUMAN | ASNS | physical | 22863883 | |
CAN2_HUMAN | CAPN2 | physical | 22863883 | |
IF5_HUMAN | EIF5 | physical | 22863883 | |
AGAL_HUMAN | GLA | physical | 22863883 | |
PDIA4_HUMAN | PDIA4 | physical | 22863883 | |
PP1A_HUMAN | PPP1CA | physical | 22863883 | |
RISC_HUMAN | SCPEP1 | physical | 22863883 | |
1433E_HUMAN | YWHAE | physical | 22863883 | |
1433G_HUMAN | YWHAG | physical | 22863883 | |
1433F_HUMAN | YWHAH | physical | 22863883 | |
GABT_HUMAN | ABAT | physical | 26344197 | |
CATA_HUMAN | CAT | physical | 26344197 | |
CPT2_HUMAN | CPT2 | physical | 26344197 | |
FAH2A_HUMAN | FAHD2A | physical | 26344197 | |
AATC_HUMAN | GOT1 | physical | 26344197 | |
HIBCH_HUMAN | HIBCH | physical | 26344197 | |
PRDX5_HUMAN | PRDX5 | physical | 26344197 | |
DHSO_HUMAN | SORD | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
266100 | Pyridoxine-dependent epilepsy (PDE) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...